In liver cholangiocarcinoma and renal cell carcinoma, TACSTD2 silencing by promoter hypermethylation was associated with enhanced aggressiveness properties such as proliferation, migration, metastasis or advanced tumor stage20,21. The gene discussed is TACSTD2; the disease is neoplasm.